<DOC>
	<DOCNO>NCT01582048</DOCNO>
	<brief_summary>Feasibility toxicity peritransplantation immunosuppression ATG , sirolimus , mycophenolate mofetil rituximab patient receive mismatch allogeneic HCT reduce intensity condition regimen fludarabine/treosulfan</brief_summary>
	<brief_title>Multicenter Study Peritransplantation Immunosuppression Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning</brief_title>
	<detailed_description />
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Treosulfan</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Patients schedule mismatched allogeneic HCT Unrelated donor maximal 2 antigen allelic mismatch HLAI HLAII Age &gt; =75 , &gt; =18 year Patients Age &lt; =50 HCTCI score &gt; 2 [ acc . Sorror et al. , 2005 ] Karnofsky Index &gt; 60 % Patients : Acute myeloid leukemia CR ( &lt; 5 % blast ) Acute lymphoblastic leukemia CR ( &lt; 5 % blast ) Myelodysplastic syndrome 20 % blast Osteomyelofibrosis Chronic lymphocytic leukemia High grade NonHodgkin Lymphoma CR PR Low grad NonHodgkin Lymphoma CR PR M. Hodgkin CR PR Chronic myeloid leukaemia chronic phase CR blast crisis Patients &gt; 5 % blast BM time transplantation Progressive chemorefractory disease Less 3 month precede HCT CNS involvement disease Fungal infection radiological progression receipt amphotericin B active triazole great 1 month . Liver function abnormality bilirubin &gt; 2 mg/dL elevation transaminases high 2x upper limit normal . Chronic active viral hepatitis Ejection fraction &lt; 40 % echocardiography Patients &gt; grade II hypertension CTC criterion Creatinine clearance &lt; 50 ml/min Proteinuria &gt; 800 mg/24 h Respiratory failure necessitate supplemental oxygen DLCO &lt; 30 % Allergy murine antibody Known allergy/intolerance sirolimus one 's excipients HIVInfection Female patient pregnant breast feeding , adult reproductive potential employ effective method birth control study treatment least 12 month thereafter . ( Women childbearing potential must negative serum pregnancy test study entry ) Concurrent severe and/or uncontrolled medical disease ( e.g . uncontrolled diabetes , congestive heart failure , myocardial infarction within 6 month prior study , unstable uncontrolled hypertension , chronic renal disease , active uncontrolled infection ) could compromise participation study Patients history psychiatric illness condition could interfere ability understand requirement study ( include alcoholism/drug addiction ) Patients unwilling unable comply protocol Unable give inform consent Enrollment trial interfere endpoint study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>